Tagged clinical-trial-data
Press Release
First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable disease
Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 months
Biomarker analysis confirms immune activation in the tumor microenvironment
Data Presented at Society for Immunotherapy of Cancer on November 8, 2024
Read More
Press Release
Make Better Pharmaceutical Portfolio Decisions - Using Failure Rates to Understand Portfolio Risks and Improve R&D Productivity, New Webinar Hosted by Xtalks
Numerous studies have analyzed R&D productivity and measured drug approval rates, but an analysis focused on success rates has limitations, providing only one piece to the puzzle. Read More
Press Release
An Automated Approach to Global Adverse Event Reporting in Pharmacovigilance, New Webinar Hosted by Xtalks
Session will help practitioners understand the benefits of using the tool and how organizations can proactively manage receipt acknowledgements, oversee distribution from a user-friendly dashboard and increase overall compliance in a cost-effective way through automation Read More
Press Release